American Society of Hematology

$In the OBS’CEREVANCE longitudinal cohort, 355 of 1803 subjects with autoimmune cytopenias (AIC) had at least 1 ANA titer ≥ 160. Among this group, the time course of SLE-free survival differed markedly by the initial cytopenia: chronic ITP (c-ITP) is shown in blue, AIHA is shown in green, and Evans syndrome (ES) is shown in red. Only a fraction of the patients in each group went on to develop lupus, with a median delay of 3.4 years (range, 0.3-15.5). See Figure 1 in the article by Granel et al, which begins on page 1576.$

In the OBS’CEREVANCE longitudinal cohort, 355 of 1803 subjects with autoimmune cytopenias (AIC) had at least 1 ANA titer ≥ 160. Among this group, the time course of SLE-free survival differed markedly by the initial cytopenia: chronic ITP (c-ITP) is shown in blue, AIHA is shown in green, and Evans syndrome (ES) is shown in red. Only a fraction of the patients in each group went on to develop lupus, with a median delay of 3.4 years (range, 0.3-15.5). See Figure 1 in the article by Granel et al, which begins on page 1576.

This Feature Is Available To Subscribers Only